Sunday, May 16, 2021

New inhibitor against key leukemia protein

Researchers have develop first-in-class inhibitors against ASH1L, a key protein in the development and progression of leukemia.

from Top Health News -- ScienceDaily https://ift.tt/3hufFHf
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Study finds untreated sleep apnea doubles Parkinson’s risk

A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lowe...